-
Moffitt Cancer Center in Tampa helped study the imaging drug, which the FDA recently approved. It draws attention to hard-to-spot tumors during surgery.
-
The verdict, reportedly the largest ever in such a case, was awarded to 22 women and their families who claim asbestos in the powder contributed to their ovarian cancer. The company plans an appeal.